Top 5 Diversified Bank Companies To Invest In Right Now

Top 5 Diversified Bank Companies To Invest In Right Now: Alkermes Inc.(ALKS)

Alkermes plc, an integrated biotechnology company, develops medicines that enhance patient outcomes. The company has a diversified portfolio of approximately 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as addiction, schizophrenia, and depression. It manufactures and commercializes VIVITROL for alcohol and opioid dependence; RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia; AMPYRA to improve walking in patients with multiple sclerosis; and BYDUREON for the treatment of type II diabetes. Alkermes? pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction, and diabetes. The company was founded in 1987 and headquartered in Dublin, Ireland.

Advisors' Opinion:

• [By Ben Levisohn]

  Going through his papers, he found a list of stocks that UBS said to buy if Obama won the election in 2012, including the likes of United Rentals (URI) , First Solar (FSLR), Alliant Techsystems (ATK), Alkermes (ALKS) and Mohawk Industries (MHK). And wouldn’t you know it, those stocks have gained 58% this year, compared to the S&P 500′s 27% gain. And just in case you’re wondering, those stocks have also trumped UBS’s Romney basket, which has gained 33%.

• [By MONEYMORNING]

  That story suggested Jazz Pharmaceuticals PLC (Nasdaq: JAZZ) and Alkermes PLC (Nasdaq: ALKS) could be targets, as well.

  More drug stocks to buy now: One of the big organic and strategic growth opportunities for the pharmaceutical industry is for generic drugs in the emerging markets. Take a look at four ways to capitalize on this! trend.

• [By Sean Williams]

  What: Shares of Alkermes (NASDAQ: ALKS  ) , a diversified biopharmaceutical company, rose as much as 16% after the company announced positive clinical results for ALKS-5461 in a mid-stage trial to treat major depressive disorder, or MDD.

source from Top Stocks Blog:http://www.topstocksblog.com/top-5-diversified-bank-companies-to-invest-in-right-now-2.html